Page last updated: 2024-08-24

toxoflavin and Osteogenic Sarcoma

toxoflavin has been researched along with Osteogenic Sarcoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ee, PL; Leow, PC; Ong, ZY; Tian, Q; Yang, Z	1

Other Studies

1 other study(ies) available for toxoflavin and Osteogenic Sarcoma

Article	Year
Antitumor activity of natural compounds, curcumin and PKF118-310, as Wnt/β-catenin antagonists against human osteosarcoma cells. Investigational new drugs, 2010, Volume: 28, Issue:6 Topics: Antineoplastic Agents; beta Catenin; Biological Products; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Proliferation; Cell Survival; Curcumin; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Humans; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Osteosarcoma; Pyrimidinones; Signal Transduction; Triazines; Wnt Proteins	2010

Article

Year

Antitumor activity of natural compounds, curcumin and PKF118-310, as Wnt/β-catenin antagonists against human osteosarcoma cells.

Investigational new drugs, 2010, Volume: 28, Issue:6

Topics: Antineoplastic Agents; beta Catenin; Biological Products; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Proliferation; Cell Survival; Curcumin; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Humans; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Osteosarcoma; Pyrimidinones; Signal Transduction; Triazines; Wnt Proteins

2010